SARS and MERS: recent insights into emerging coronaviruses

By E. de Wit, Neeltje van Doremalen, D. Falzarano, V. Munster. Nature Reviews Microbiology, 2016

3,317 citations recorded by the source corpus.

The emergence of Middle East respiratory syndrome coronavirus (MERS-CoV) in 2012 marked the second introduction of a highly pathogenic coronavirus into the human population in the twenty-first century. The continuing introductions of MERS-CoV from dromedary camels, the subsequent travel-related viral spread, the unprecedented nosocomial outbreaks and the high case-fatality rates highlight the need for prophylactic and therapeutic measures. Scientific advancements since the 2002–2003 severe acute respiratory syndrome coronavirus (SARS-CoV) pandemic allowed for rapid progress in our understanding of the epidemiology and pathogenesis of MERS-CoV and the development of therapeutics. In this Review, we detail our present understanding of the transmission and pathogenesis of SARS-CoV and MERS-CoV, and discuss the current state of development of measures to combat emerging coronaviruses.

Subfields: Infectious Diseases, Modeling and Simulation

View Paper: https://www.semanticscholar.org/paper/c377338a2eb14de7671d992d4c1aa735bb661617

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

In Infectious Diseases

  1. Jun Zheng
  2. Hannah Kleine-Weber
  3. Scott Weaver
  4. Yu Chen
  5. S. Pöhlmann
  6. Christian Drosten
  7. David Gurwitz
  8. M. Hoffmann

In Modeling and Simulation

  1. N. Curtis
  2. Jun Zheng
  3. Petra Zimmermann

Citations in the corpus